KIF11 and glioblastoma: Although we had previously shown that the KIF11 inhibitor ispinesib is capable of crossing the BBB and prolonging survival in a patient-derived xenograft model of GBM, we suspected that active extrusion of this hydrophobic therapeutic might limit its ability to control this disease7.